Q3 2021 Holdings
Filed 2021-11-15 | 102 holdings | $1.4B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY)A | COM | 110122108 | $27.8M | 464,801 | 1.9% |
| Vertex Pharmaceuticals Inc(VRTX)CallA | COM | 92532F100 | $31.4M | 173,300 | 2.2% |
| Mckesson Corp(MCK)A | COM | 58155Q103 | $32.3M | 161,708 | 2.2% |
| Envista Holdings Corporation(NVST)A | COM | 29415F104 | $33.9M | 810,881 | 2.4% |
| Teva Pharmaceutical Inds LTD(TEVA)A | SPONSORED ADS | 881624209 | $34.6M | 3,554,804 | 2.4% |
| Laboratory Corp Amer HldgsA | COM NEW | 50540R409 | $36.1M | 128,311 | 2.5% |
| Amneal Pharmaceuticals Inc(AMRX)A | COM STK CL A | 03168L105 | $36.6M | 6,849,834 | 2.5% |
| Spdr S&P 500 ETF TR(SPY)PutA | TR UNIT | 78462F103 | $42.9M | 100,000 | 3.0% |
| Danaher Corporation(DHR)A | COM | 235851102 | $45.1M | 147,938 | 3.1% |
| ARK ETF TR(ARKG)A | GENOMIC REV ETF | 00214Q302 | $51.5M | 689,501 | 3.6% |
| Avantor Inc(AVTR)A | COM | 05352A100 | $52.8M | 1,292,014 | 3.7% |
| Astrazeneca PLC(AZN)A | SPONSORED ADR | 046353108 | $53.5M | 890,808 | 3.7% |
| Glaxosmithkline PLCCallA | SPONSORED ADR | 37733W105 | $57.5M | 1,503,700 | 4.0% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $59.2M | 11,604,990 | 4.1% |
| Acceleron Pharma Inc(XLRN)A | COM | 00434H108 | $60.1M | 349,494 | 4.2% |
| Horizon Therapeutics PUB LA | SHS | G46188101 | $69.5M | 634,670 | 4.8% |
| Community Health SYS Inc New(CYH)A | COM | 203668108 | $70.1M | 5,988,163 | 4.9% |
| Ascendis Pharma A/S(ASND)A | SPONSORED ADR | 04351P101 | $71.0M | 445,203 | 4.9% |
| United Therapeutics Corp del(UTHR)A | COM | 91307C102 | $82.0M | 444,471 | 5.7% |